Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMPICILLIN for Foetal exposure during pregnancy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 211 adverse event reports in the FDA FAERS database where AMPICILLIN was used for Foetal exposure during pregnancy.

Most Reported Side Effects for AMPICILLIN

Side Effect Reports % Deaths Hosp.
Drug hypersensitivity 566 15.5% 0 58
Drug ineffective 540 14.8% 186 282
Maternal exposure during pregnancy 485 13.3% 7 52
Foetal exposure during pregnancy 474 13.0% 64 92
Premature baby 404 11.1% 45 64
Premature delivery 330 9.0% 0 15
Product use in unapproved indication 224 6.1% 6 20
Off label use 204 5.6% 52 99
Rash 150 4.1% 5 58
Low birth weight baby 127 3.5% 11 34
Delivery 126 3.5% 0 0
Exposure during pregnancy 124 3.4% 4 27
Normal labour 123 3.4% 0 0
Diarrhoea 117 3.2% 7 56
Pyrexia 116 3.2% 14 78

Other Indications for AMPICILLIN

Product used for unknown indication (831) Antibiotic therapy (429) Antibiotic prophylaxis (144) Ureaplasma infection (142) Evidence based treatment (109) Enterococcal infection (96) Listeriosis (76) Amniotic cavity infection (66) Endocarditis (60) Urinary tract infection (59)

Other Drugs Used for Foetal exposure during pregnancy

HYDROXYPROGESTERONE CAPROATE (4,042) ONDANSETRON (1,061) ASPIRIN (485) BETAMETHASONE (475) PREDNISONE (429) ACETAMINOPHEN (428) OXYCODONE (414) LEVETIRACETAM (401) TACROLIMUS (382) LAMOTRIGINE (343)

Related Pages

AMPICILLIN Full Profile All Foetal exposure during pregnancy Drugs AMPICILLIN Demographics AMPICILLIN Timeline